NeuroKaire

NeuroKaire is a biotechnology company focused on precision medicine in psychiatry and neurology. They've developed a clinical test using a simple blood draw to identify drug efficacy for depression patients based on neuronal response and clinical data. This innovative approach aims to optimize antidepressant selection for individual patients, leading to faster treatment and fewer side effects.

Funding Round:

Funding Amount: $10M

Date: 17-Dec-2024

Investors: GreyBird Ventures, Meron Capital, Jumpspeed Ventures

Markets: Biotechnology, Health Care, Personal Health, Psychology

HQ: Kearny, New Jersey, United States

Founded: 2018

Website: https://www.neurokaire.com/

LinkedIn: https://www.linkedin.com/company/neurokaire/

Twitter: https://twitter.com/neurokaire

Instagram:

Facebook: https://www.facebook.com/neurokaire